Get started
JAFRON BIOMEDICALJAFRON BIOMEDICALJAFRON BIOMEDICAL

JAFRON BIOMEDICAL

No trades
See on Supercharts
Overview
Financials
News Ideas Discussions Technicals Forecast Seasonals

300529 fundamentals

Key facts

Market capitalization—
Dividend yield (indicated)—
Price to earnings Ratio (TTM)—
Basic EPS (TTM)—
Founded—
Employees (FY)—
CEO—
Website—
About

Jafron Biomedical Co., Ltd. engages in the research, development, production, and sale of hemoperfusion products. Its products include HA series hemoperfusion cartridge, BS bilirubin adsorption column, DNA immunoadsorption column, hemoperfusion machine, blood purification machine and other products. The company was founded on December 19, 1989 and is headquartered in Zhuhai, China.

Valuation

Fundamental metrics to determine fair value of the stock

Summary
No data available
There's currently no market capitalization, revenue or net income data to show.
Valuation ratios

Growth and Profitability

Company’s recent performance and margins

Dividends

Dividend yield, history and sustainability

No dividends
300529 has never paid dividends and has no current plans to do so.

Financial health

Financial position and solvency of the company